135 related articles for article (PubMed ID: 33321015)
1. Development of pancreatic injuries in the course of COVID-19.
Akkus C; Yilmaz H; Mizrak S; Adibelli Z; Akdas O; Duran C
Acta Gastroenterol Belg; 2020; 83(4):585-592. PubMed ID: 33321015
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients with acute pancreatitis associated with SARS-CoV-2 (COVID-19); The importance of lipase/lymphocyte ratio in predicting mortality.
Haydar FG; Otal Y; Avcioglu G
Bratisl Lek Listy; 2022; 123(6):428-434. PubMed ID: 35576544
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.
Ahmed A; Fisher JC; Pochapin MB; Freedman SD; Kothari DJ; Shah PC; Sheth SG
Pancreatology; 2021 Jun; 21(4):698-703. PubMed ID: 33741267
[TBL] [Abstract][Full Text] [Related]
4. Rare presentation of acute pancreatitis in mild COVID-19.
Hatch-Vallier B; Jarodiya V; Hawa F; Daniel R
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34799394
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Investigation of factors affecting COVID-19 pancreatic injury: a single-center, retrospective study.
Komatsu S; Yatabe T; Hara Y; Kuriyama N; Nakamura T; Nishida O
J Anesth; 2023 Jun; 37(3):487-491. PubMed ID: 36930274
[TBL] [Abstract][Full Text] [Related]
7. Association between Acute Pancreatitis and COVID-19: Could Pancreatitis Be the Missing Piece of the Puzzle about Increased Mortality Rates?
Akarsu C; Karabulut M; Aydin H; Sahbaz NA; Dural AC; Yegul D; Peker KD; Ferahman S; Bulut S; Dönmez T; Asar S; Yasar KK; Adas GT
J Invest Surg; 2022 Jan; 35(1):119-125. PubMed ID: 33138658
[TBL] [Abstract][Full Text] [Related]
8. A bimodal pattern of the onset of COVID-19 related acute pancreatitis supports both the cytotoxic and immune-related pathogenesis - a systematic review.
Bircakova B; Bruha R; Lambert L; Grusova G; Michalek P; Burgetova A
Scand J Gastroenterol; 2021 Jul; 56(7):870-873. PubMed ID: 33989101
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Acute Pancreatitis: A Systematic Review of Case Reports and Case Series.
Georgakopoulou VE; Gkoufa A; Garmpis N; Makrodimitri S; Papageorgiou CV; Barlampa D; Garmpi A; Chiapoutakis S; Sklapani P; Trakas N; Damaskos C
Ann Saudi Med; 2022; 42(4):276-287. PubMed ID: 35933608
[TBL] [Abstract][Full Text] [Related]
10. Does Hyperlipasemia Predict Worse Clinical Outcomes in COVID-19? A Multicenter Retrospective Cohort Study.
Singh RR; Chhabra P; Kumta NA
J Clin Gastroenterol; 2022 Mar; 56(3):e227-e231. PubMed ID: 34294655
[TBL] [Abstract][Full Text] [Related]
11. Lipase elevation on admission predicts worse clinical outcomes in patients with COVID-19.
Kiyak M; Düzenli T
Pancreatology; 2022 Jun; 22(5):665-670. PubMed ID: 35537935
[TBL] [Abstract][Full Text] [Related]
12. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value.
Caruso S; Aloisio E; Dolci A; Panteghini M
Clin Chem Lab Med; 2022 Jan; 60(1):135-142. PubMed ID: 34687597
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic injury and acute pancreatitis in COVID-19 patients.
Cienfuegos JA; Almeida A; Aliseda D
Rev Esp Enferm Dig; 2021 May; 113(5):389. PubMed ID: 33569964
[TBL] [Abstract][Full Text] [Related]
14. Lipase Elevation in Patients With COVID-19.
McNabb-Baltar J; Jin DX; Grover AS; Redd WD; Zhou JC; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW
Am J Gastroenterol; 2020 Aug; 115(8):1286-1288. PubMed ID: 32496339
[TBL] [Abstract][Full Text] [Related]
15. Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review.
Juhász MF; Ocskay K; Kiss S; Hegyi P; Párniczky A
World J Gastroenterol; 2020 Oct; 26(40):6270-6278. PubMed ID: 33177799
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and acute biliary pancreatitis: comparative analysis between the normal period and COVID-19 pandemic.
Meric S; Aktokmakyan TV; Tokocin M; Aktimur YE; Hacim NA; Yavuz E
Ann Ital Chir; 2021; 92():728-731. PubMed ID: 35166231
[TBL] [Abstract][Full Text] [Related]
17. A case-control emergency department-based analysis of acute pancreatitis in Covid-19: Results of the UMC-19-S
Miró Ò; Llorens P; Jiménez S; Piñera P; Burillo-Putze G; Martín A; Martín-Sánchez FJ; Lamberechts J; Alquézar-Arbé A; Jacob J; Noceda J; Cano Cano MJ; Fortuny Bayarri MJ; Marín Porrino JM; Meléndez N; Pérez García C; Brasó Aznar JV; Ponce MC; Díaz Fernández E; Ejarque Martínez L; Peiró Gómez A; Tost J; Domínguez MJ; Teigell Muñoz FJ; González Del Castillo J;
J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):953-966. PubMed ID: 33259695
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Acute Pancreatitis in a Patient with COVID-19 Infection.
Cheung S; Delgado Fuentes A; Fetterman AD
Am J Case Rep; 2020 Aug; 21():e927076. PubMed ID: 32833954
[TBL] [Abstract][Full Text] [Related]
19. DOES COVID-19 CAUSE PANCREATITIS?
EBiK B; Bacaksiz F; EKiN N
Arq Gastroenterol; 2022; 59(1):71-74. PubMed ID: 35442340
[TBL] [Abstract][Full Text] [Related]
20. High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome.
Rasch S; Herner A; Schmid RM; Huber W; Lahmer T
Pancreatology; 2021 Jan; 21(1):306-311. PubMed ID: 33277183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
